top of page
Brain Surgeon

At the forefront of innovation in tissue matching ultrasound couplants

SonoClear at a glance

COMPANY

SonoClear was established in 2016 as a spin-off from the ultrasound and image guided therapy centre in Trondheim, Norway. Trondheim is a world recognised cluster for innovation and development in industrial and medical ultrasound.

COMPANY

SonoClear in numbers

2

Publications

5

Patents

59

Treated patients

FUNDRAISING

Our investors and

financial support

MISSION

Are you interested in joining our mission?

For those interested in exploring investment opportunities with SonoClear, we invite you to connect and reach out to us:

Innovation through collaboration

Surgeons and engineers from St. Olavs Hospital, NTNU (Norwegian University of Science and Technology) and the research foundation SINTEF have collaborated for more than 20 years to develop new techniques for intraoperative ultrasound guided surgery.

2009 – 2012

Preclinical testing.

2013 – 2016

Phase 1 clinical investigation. 15 Glioblastoma patients (St Olav’s Hospital)

2017 – 2022

Early prototype testing, Verification and Validation studies, Regulatory strategy, Initiation of phase 1 of pivotal multi-centre clinical investigation in high- and low-grade Glioma patients. (Germany, Italy and Slovakia). COVID-19

2023

Appointment of Peter Balmforth as CEO, Completion of phase 1 of pivotal multi-centre clinical investigation.

bottom of page